Return to search

Self-adjusting doses of oral antihyperglycemic therapy using repaglinide or glyburide in type 2 diabetes : the soaring study

No description available.
Identiferoai:union.ndltd.org:mcgill.ca/oai:escholarship.mcgill.ca:3b591884d
Date January 2006
CreatorsMacKinnon, Lindsay M.
PublisherMcGill University
Source SetsMcGill University
Languagehttp://id.loc.gov/vocabulary/iso639-2/eng
Detected LanguageEnglish
TypeThesis
RightsAll items in eScholarship@McGill are protected by copyright with all rights reserved unless otherwise indicated., © Lindsay M. MacKinnon, 2006
RelationPid: 98758, Proquest: AAIMR24729

Page generated in 0.0018 seconds